| Utestående aktier | 78,510,318 shares |
| Insideraktier | 18 497 006 shares |
| Insynsägande | 23,56 % |
| Totalt antal insynspersoner | 34 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
5284 out of 11224Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Clearside Biomedical, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Cagle Gerald D. Director - [D] | 80 145 | 80 145 | |
|
Bihua Chen
Director, 10% Owner -
[D]
|
3 976 416 | 3 976 416 | |
| Ngai Hang Victor Chong Chief Medical Officer - [O] | 100 000 | 100 000 | |
| Thomas Ciulla Chief Medical Officer - [O] | 291 890 | 291 890 | |
|
Cormorant Asset Management, LLC
10% Owner -
|
3 976 416 | 3 976 416 | |
|
Cormorant Global Healthcare GP, LLC
10% Owner -
|
3 976 416 | 3 976 416 | |
|
Cormorant Global Healthcare Master Fund, LP
10% Owner -
|
3 976 416 | 3 976 416 | |
| Richard Croarkin | 25 000 | ||
|
John Crumpler
10% Owner -
|
1 757 719 | 1 757 719 | |
| Deignan Charles A. Chief Financial Officer - [O] | 384 662 | 384 662 | |
| Jeffrey L Edwards | 25 000 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Anthony S Gibney Director - [D] | 100 000 | 100 000 | |
|
Hatteras Venture Advisors III, LLC
10% Owner -
|
1 757 719 | 1 757 719 | |
|
Hatteras Venture Advisors IV SBIC, LLC
10% Owner -
|
2 060 514 | 2 060 514 | |
|
Hatteras Venture Affiliates III Lp
10% Owner -
|
1 757 719 | 1 757 719 | |
|
Hatteras Venture Partners IV SBIC, LP
10% Owner -
|
2 060 514 | 2 060 514 | |
|
Hatteras Ventures Partners III LP
10% Owner -
|
1 757 719 | 1 757 719 | |
| Humphries William D. Director - [D] | 51 040 | 51 040 | |
| Nancy J Hutson Director - [D] | 93 000 | 93 000 | |
|
Robert Alexander Ingram
10% Owner -
|
1 757 719 | 1 757 719 | |
| George M Lasezkay CEO, Director - [D] [O] | 466 577 | 466 577 | |
|
Kenneth B Jr Lee
10% Owner -
|
1 757 719 | 1 757 719 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Glenn Noronha | 96 000 | ||
|
RMI Investments S.a.r.l.
10% Owner -
|
1 558 024 | 1 558 024 | |
| Raymond Brion S. Chief Commercial Officer - [O] | 50 000 | 50 000 | |
|
Douglas MD Reed
10% Owner -
|
1 757 719 | 1 757 719 | |
|
RusnanoMedInvest LLC
10% Owner -
|
1 558 024 | 1 558 024 | |
| Christy L Shaffer Director - [D] | 4 400 | 4 400 | |
|
Clay Thorp
Director, 10% Owner -
[D]
|
176 141 | 176 141 | |
|
Bradford T Whitmore
10% Owner -
|
6 845 186 | 6 845 186 | |
| White Daniel H. President and CEO, Director - [D] [O] | 483 335 | 483 335 | |
| Benjamin R Yerxa Director - [D] | 17 957 | 17 957 | |
| Derek Yoon | 2 632 | ||
| Evgeny Zaytsev | 11 250 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CLSD / Clearside Biomedical, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CLSD / Clearside Biomedical, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-24 | 2025-02-24 | 4 | Thorp Clay | CLSD | Common Stock | D | 0,9200 | 15 000 | 14 | 176 141 | ||||
| 2024-11-04 | 2024-11-01 | 4 | Chong Ngai Hang Victor | CLSD | Common Stock | D | 1,0000 | 36 500 | 36 | 100 000 | ||||
| 2024-06-24 | 3/A | Chong Ngai Hang Victor | CLSD | Common Stock | D | 10 000 | ||||||||
| 2024-06-24 | 2024-06-24 | 4 | Chong Ngai Hang Victor | CLSD | Common Stock | D | 1,0600 | 23 500 | 25 | 63 500 | ||||
| 2024-05-15 | 2024-05-15 | 4 | YERXA BENJAMIN R | CLSD | Common Stock | D | 1,3100 | 7 813 | 10 | 17 957 | ||||
| 2024-04-19 | 2024-04-18 | 4 | Gibney Anthony S | CLSD | Common Stock | D | 1,3000 | 93 290 | 121 | 100 000 | ||||
| 2024-04-19 | 2024-04-17 | 4 | Gibney Anthony S | CLSD | Common Stock | D | 1,2500 | 6 710 | 8 | 6 710 | ||||
| 2024-03-20 | 2024-03-20 | 4 | Chong Ngai Hang Victor | CLSD | Common Stock | D | 1,6000 | 30 000 | 48 | 30 000 | ||||
| 2024-02-09 | 2024-02-07 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 1,3500 | 444 444 | 600 | 4 495 034 | ||||
| 2024-01-19 | 2024-01-19 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 1,2700 | −18 000 | −23 | 466 577 | ||||
| 2024-01-19 | 2024-01-19 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 1,2800 | −12 900 | −17 | 384 662 | ||||
| 2023-11-01 | 2023-11-01 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 0,7442 | 64 366 | 48 | 4 050 590 | ||||
| 2023-11-01 | 2023-10-31 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 0,7278 | 70 812 | 52 | 3 986 224 | ||||
| 2023-11-01 | 2023-10-30 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 0,6850 | 600 | 0 | 3 915 412 | ||||
| 2023-11-01 | 3 | WHITMORE BRADFORD T by Grace Brothers, LP | CLSD | Common Stock | I | 2 350 152 | ||||||||
| 2023-11-01 | 3 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 3 914 812 | ||||||||
| 2023-10-04 | 2023-10-03 | 4 | Hutson Nancy J | CLSD | Common Stock | D | 0,8600 | 10 000 | 9 | 93 000 | ||||
| 2023-09-25 | 2023-09-25 | 4 | Thorp Clay | CLSD | Common Stock | D | 0,8600 | 10 000 | 9 | 40 522 | ||||
| 2023-09-22 | 2023-09-22 | 4 | Humphries William D. | CLSD | Common Stock | D | 0,4000 | 22 727 | 9 | 51 040 | ||||
| 2023-09-13 | 2023-09-13 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 0,4000 | 34 090 | 14 | 397 562 | ||||
| 2023-01-20 | 2023-01-19 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 1,5000 | −14 030 | −21 | 363 472 | ||||
| 2023-01-20 | 2023-01-19 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 1,4600 | −20 030 | −29 | 484 577 | ||||
| 2023-01-20 | 2023-01-20 | 4 | Ciulla Thomas | CLSD | Common Stock | D | 1,4700 | −13 700 | −20 | 291 890 | ||||
| 2023-01-11 | 2023-01-10 | 4 | Ciulla Thomas | CLSD | Common Stock | D | 1,6200 | −2 170 | −4 | 305 590 | ||||
| 2023-01-06 | 2022-12-31 | 4 | Ciulla Thomas | CLSD | Common Stock | D | 0,9500 | 5 000 | 5 | 307 760 | ||||
| 2023-01-06 | 2022-06-30 | 4 | Ciulla Thomas | CLSD | Common Stock | D | 1,2500 | 5 000 | 6 | 302 760 | ||||
| 2022-12-21 | 2022-12-21 | 4 | Thorp Clay | CLSD | Common Stock | D | 1,0190 | 14 000 | 14 | 30 522 | ||||
| 2022-12-20 | 2022-12-20 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 0,4000 | 23 636 | 9 | 377 502 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Thorp Clay | CLSD | Common Stock | D | 8 522 | 16 522 | ||||||
| 2022-12-19 | 2022-12-15 | 4 | Thorp Clay | CLSD | Common Stock | I | −1 406 507 | 3 545 040 | ||||||
| 2022-12-19 | 2021-02-10 | 4/A | Thorp Clay | CLSD | Common Stock | D | 4,4300 | −32 873 | −146 | 4 951 547 | ||||
| 2022-11-21 | 2022-11-17 | 4 | Hutson Nancy J | CLSD | Common Stock | D | 1,3300 | 30 000 | 40 | 83 000 | ||||
| 2022-03-04 | 2022-03-02 | 4 | YERXA BENJAMIN R | CLSD | Stock Option (right to buy) | D | 1,49 | 30 000 | 30 000 | |||||
| 2022-03-04 | 3 | YERXA BENJAMIN R | CLSD | Common Stock | D | 10 144 | ||||||||
| 2022-01-28 | 2022-01-18 | 4/A | Ciulla Thomas | CLSD | Stock Option (Right to Buy) | D | 2,19 | 138 750 | 138 750 | |||||
| 2022-01-28 | 2022-01-18 | 4/A | Ciulla Thomas | CLSD | Common Stock | D | 46 250 | 301 810 | ||||||
| 2022-01-28 | 2022-01-18 | 4/A | Deignan Charles A. | CLSD | Stock Option (Right to Buy) | D | 2,19 | 138 750 | 138 750 | |||||
| 2022-01-28 | 2022-01-18 | 4/A | Deignan Charles A. | CLSD | Common Stock | D | 46 250 | 362 699 | ||||||
| 2022-01-20 | 2022-01-19 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 2,0900 | −8 833 | −18 | 351 366 | ||||
| 2022-01-20 | 2022-01-18 | 4 | Deignan Charles A. | CLSD | Stock Option (Right to Buy) | D | 2,19 | 131 250 | 131 250 | |||||
| 2022-01-20 | 2022-01-18 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 43 750 | 360 199 | ||||||
| 2022-01-20 | 2022-01-19 | 4 | Ciulla Thomas | CLSD | Common Stock | D | 2,1300 | −9 050 | −19 | 295 260 | ||||
| 2022-01-20 | 2022-01-18 | 4 | Ciulla Thomas | CLSD | Stock Option (Right to Buy) | D | 2,19 | 131 250 | 131 250 | |||||
| 2022-01-20 | 2022-01-18 | 4 | Ciulla Thomas | CLSD | Common Stock | D | 43 750 | 299 310 | ||||||
| 2022-01-20 | 2022-01-19 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 2,1200 | −10 800 | −23 | 504 607 | ||||
| 2022-01-20 | 2022-01-18 | 4 | LASEZKAY GEORGE M | CLSD | Stock Option (Right to Buy) | D | 2,19 | 292 500 | 292 500 | |||||
| 2022-01-20 | 2022-01-18 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 97 500 | 515 407 | ||||||
| 2022-01-13 | 2022-01-11 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 2,4600 | −5 100 | −13 | 417 907 | ||||
| 2022-01-11 | 2022-01-10 | 4 | Humphries William D. | CLSD | Stock Option (right to buy) | D | 0,15 | −22 727 | 0 | |||||
| 2022-01-11 | 2022-01-10 | 4 | Humphries William D. | CLSD | Common Stock | D | 0,1500 | 22 727 | 3 | 28 313 | ||||
| 2021-11-02 | 2021-10-29 | 4 | Hutson Nancy J | CLSD | Stock Option (right to buy) | D | 2,09 | −15 000 | 15 000 | |||||
| 2021-11-02 | 2021-10-29 | 4 | Hutson Nancy J | CLSD | Stock Option (right to buy) | D | 2,00 | −25 000 | 0 | |||||
| 2021-11-02 | 2021-10-29 | 4 | Hutson Nancy J | CLSD | Common Stock | D | 2,0900 | 15 000 | 31 | 53 000 | ||||
| 2021-11-02 | 2021-10-29 | 4 | Hutson Nancy J | CLSD | Common Stock | D | 2,0000 | 25 000 | 50 | 38 000 | ||||
| 2021-09-23 | 2021-09-21 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 6,4100 | −2 800 | −18 | 316 449 | ||||
| 2021-09-23 | 2021-09-21 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 6,4600 | −3 525 | −23 | 423 007 | ||||
| 2021-09-23 | 2021-09-21 | 4 | Ciulla Thomas | CLSD | Common Stock | D | 6,4000 | −2 560 | −16 | 255 560 | ||||
| 2021-09-01 | 2021-09-01 | 4 | WHITMORE BRADFORD T by Grace Brothers, LP | CLSD | Common Stock | I | 6,8913 | −213 203 | −1 469 | 2 415 056 | ||||
| 2021-09-01 | 2021-08-31 | 4 | WHITMORE BRADFORD T by Grace Brothers, LP | CLSD | Common Stock | I | 6,9564 | −107 682 | −749 | 2 628 259 | ||||
| 2021-09-01 | 2021-08-30 | 4 | WHITMORE BRADFORD T by Grace Brothers, LP | CLSD | Common Stock | I | 7,0634 | −99 400 | −702 | 2 735 941 | ||||
| 2021-08-17 | 2021-08-16 | 4 | Hutson Nancy J | CLSD | Common Stock | D | 5,6800 | 3 000 | 17 | 13 000 | ||||
| 2021-06-23 | 2021-06-21 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 4,3800 | −3 707 | −16 | 426 532 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 4,3700 | −2 938 | −13 | 319 249 | ||||
| 2021-06-11 | 2021-06-10 | 4 | Hutson Nancy J | CLSD | Stock Option (right to buy) | D | 3,11 | 25 000 | 25 000 | |||||
| 2021-06-11 | 2021-06-10 | 4 | Croarkin Richard | CLSD | Stock Option (right to buy) | D | 3,11 | 25 000 | 25 000 | |||||
| 2021-06-11 | 2021-06-10 | 4 | EDWARDS JEFFREY L | CLSD | Stock Option (right to buy) | D | 3,11 | 25 000 | 25 000 | |||||
| 2021-06-11 | 2021-06-10 | 4 | Humphries William D. | CLSD | Stock Option (right to buy) | D | 3,11 | 25 000 | 25 000 | |||||
| 2021-06-11 | 2021-06-10 | 4 | Thorp Clay | CLSD | Stock Option (right to buy) | D | 3,11 | 25 000 | 25 000 | |||||
| 2021-06-11 | 2021-06-10 | 4 | SHAFFER CHRISTY L | CLSD | Stock Option (right to buy) | D | 3,11 | 25 000 | 25 000 | |||||
| 2021-03-23 | 2021-03-19 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 2,8200 | −3 370 | −10 | 430 239 | ||||
| 2021-03-15 | 2021-03-12 | 4 | Hutson Nancy J | CLSD | Common Stock | D | 3,1050 | 5 000 | 16 | 10 000 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Ciulla Thomas | CLSD | Employee Stock Option (right to buy) | D | 5,04 | 40 000 | 40 000 | |||||
| 2021-03-03 | 2021-03-02 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 3,3700 | −6 000 | −20 | 433 609 | ||||
| 2021-02-12 | 2021-02-10 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 4,4300 | −32 873 | −146 | 3 433 521 | ||||
| 2021-01-20 | 2021-01-18 | 4 | LASEZKAY GEORGE M | CLSD | Stock Option (Right to Buy) | D | 4,01 | 284 750 | 284 750 | |||||
| 2021-01-20 | 2021-01-18 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 140 250 | 439 609 | ||||||
| 2021-01-20 | 2021-01-18 | 4 | Deignan Charles A. | CLSD | Stock Option (Right to Buy) | D | 4,01 | 195 640 | 195 640 | |||||
| 2021-01-20 | 2021-01-18 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 96 360 | 322 187 | ||||||
| 2021-01-20 | 2021-01-18 | 4 | Ciulla Thomas | CLSD | Stock Option (Right to Buy) | D | 4,01 | 209 375 | 209 375 | |||||
| 2021-01-20 | 2021-01-18 | 4 | Ciulla Thomas | CLSD | Common Stock | D | 103 125 | 253 122 | ||||||
| 2021-01-07 | 2021-01-06 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 2,8510 | 350 750 | 1 000 | 3 529 845 | ||||
| 2020-12-28 | 2020-12-24 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 1,9513 | 51 195 | 100 | 3 179 095 | ||||
| 2020-12-23 | 2020-12-21 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 2,0700 | −3 330 | −7 | 299 359 | ||||
| 2020-12-02 | 2020-12-02 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 1,9490 | 53 900 | 105 | 3 127 900 | ||||
| 2020-11-24 | 2020-11-24 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 1,6459 | 62 000 | 102 | 3 074 000 | ||||
| 2020-11-16 | 2020-11-16 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 1,6924 | 62 000 | 105 | 3 012 000 | ||||
| 2020-09-24 | 2020-09-22 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 1,5900 | −13 411 | −21 | 302 689 | ||||
| 2020-08-18 | 2020-08-18 | 4 | Humphries William D. | CLSD | Common Stock | D | 1,7800 | 5 586 | 10 | 5 586 | ||||
| 2020-08-13 | 2020-08-13 | 4/A | WHITMORE BRADFORD T | CLSD | Common Stock | D | 1,6512 | 50 000 | 83 | 2 950 000 | ||||
| 2020-08-13 | 2020-08-12 | 4/A | WHITMORE BRADFORD T | CLSD | Common Stock | D | 1,6304 | 300 000 | 489 | 2 900 000 | ||||
| 2020-08-13 | 2020-08-13 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 1,6512 | 50 000 | 83 | 2 950 000 | ||||
| 2020-08-13 | 2020-08-12 | 4 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 1,6304 | 300 000 | 489 | 2 900 000 | ||||
| 2020-06-26 | 3 | Ciulla Thomas | CLSD | Common Stock | D | 290 000 | ||||||||
| 2020-06-26 | 3 | Ciulla Thomas | CLSD | Common Stock | D | 290 000 | ||||||||
| 2020-06-26 | 3 | Ciulla Thomas | CLSD | Common Stock | D | 290 000 | ||||||||
| 2020-06-19 | 2020-06-18 | 4 | Humphries William D. | CLSD | Stock Option (right to buy) | D | 2,00 | 25 000 | 25 000 | |||||
| 2020-06-19 | 2020-06-18 | 4 | Croarkin Richard | CLSD | Stock Option (right to buy) | D | 2,00 | 25 000 | 25 000 | |||||
| 2020-06-19 | 2020-06-18 | 4 | EDWARDS JEFFREY L | CLSD | Stock Option (right to buy) | D | 2,00 | 25 000 | 25 000 | |||||
| 2020-06-19 | 2020-06-18 | 4 | SHAFFER CHRISTY L | CLSD | Stock Option (right to buy) | D | 2,00 | 25 000 | 25 000 | |||||
| 2020-06-19 | 2020-06-18 | 4 | Thorp Clay | CLSD | Stock Option (right to buy) | D | 2,00 | 25 000 | 25 000 | |||||
| 2020-06-19 | 2020-06-18 | 4 | Hutson Nancy J | CLSD | Stock Option (right to buy) | D | 2,00 | 25 000 | 25 000 | |||||
| 2020-06-03 | 2020-06-01 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 1,8800 | −14 992 | −28 | 220 827 | ||||
| 2020-05-21 | 2020-05-20 | 4 | Hutson Nancy J | CLSD | Common Stock | D | 1,8500 | 5 000 | 9 | 5 000 | ||||
| 2020-05-13 | 2020-05-12 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 1,9900 | −32 150 | −64 | 311 100 | ||||
| 2020-04-23 | 2020-04-21 | 4 | Hutson Nancy J | CLSD | Stock Option (right to buy) | D | 2,09 | 30 000 | 30 000 | |||||
| 2020-03-13 | 2020-03-11 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 50 000 | 343 250 | ||||||
| 2020-01-10 | 2020-01-08 | 4 | LASEZKAY GEORGE M | CLSD | Stock Option (Right to Buy) | D | 2,37 | 198 750 | 198 750 | |||||
| 2020-01-10 | 2020-01-08 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 66 250 | 288 250 | ||||||
| 2020-01-10 | 2020-01-08 | 4 | Deignan Charles A. | CLSD | Stock Option (Right to Buy) | D | 2,37 | 75 000 | 75 000 | |||||
| 2020-01-10 | 2020-01-08 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 25 000 | 228 856 | ||||||
| 2019-11-26 | 2019-11-22 | 4 | Thorp Clay | CLSD | Common Stock | I | 1,0540 | 1 518 026 | 1 600 | 4 984 420 | ||||
| 2019-11-26 | 3 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 8 035 341 | ||||||||
| 2019-11-26 | 3 | WHITMORE BRADFORD T by Grace Brothers, LP | CLSD | Common Stock | I | 8 270 682 | ||||||||
| 2019-11-26 | 3 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 8 035 341 | ||||||||
| 2019-11-26 | 3 | WHITMORE BRADFORD T by Grace Brothers, LP | CLSD | Common Stock | I | 8 270 682 | ||||||||
| 2019-11-26 | 3 | WHITMORE BRADFORD T by Grace Brothers, LP | CLSD | Common Stock | I | 8 270 682 | ||||||||
| 2019-11-26 | 3 | WHITMORE BRADFORD T | CLSD | Common Stock | D | 8 035 341 | ||||||||
| 2019-11-13 | 2019-11-12 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 1,1400 | 7 500 | 9 | 203 856 | ||||
| 2019-11-12 | 2019-11-11 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 1,1600 | 12 000 | 14 | 222 000 | ||||
| 2019-09-20 | 2019-09-18 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 70 000 | 196 356 | ||||||
| 2019-09-20 | 2019-09-18 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 110 000 | 210 000 | ||||||
| 2019-08-08 | 2019-08-07 | 4 | LASEZKAY GEORGE M | CLSD | Common Stock | D | 100 000 | 100 000 | ||||||
| 2019-06-24 | 2019-06-20 | 4 | EDWARDS JEFFREY L | CLSD | Stock Option (right to buy) | D | 1,07 | 20 000 | 20 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | Humphries William D. | CLSD | Stock Option (right to buy) | D | 1,07 | 20 000 | 20 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | Thorp Clay | CLSD | Stock Option (right to buy) | D | 1,07 | 20 000 | 20 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | SHAFFER CHRISTY L | CLSD | Stock Option (right to buy) | D | 1,07 | 20 000 | 20 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | Croarkin Richard | CLSD | Stock Option (right to buy) | D | 1,07 | 20 000 | 20 000 | |||||
| 2019-06-04 | 2019-05-31 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 50 000 | 126 356 | ||||||
| 2019-06-04 | 2019-05-31 | 4 | Raymond Brion S. | CLSD | Common Stock | D | 50 000 | 50 000 | ||||||
| 2019-04-10 | 2019-04-07 | 4 | LASEZKAY GEORGE M | CLSD | Stock Option (right to buy) | D | 1,40 | 250 000 | 250 000 | |||||
| 2019-03-18 | 2019-03-15 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 1,3600 | 10 000 | 14 | 76 356 | ||||
| 2019-02-07 | 2019-02-05 | 4 | White Daniel H. | CLSD | Employee Stock Option (right to buy) | D | 1,24 | 200 000 | 200 000 | |||||
| 2019-02-07 | 2019-02-05 | 4 | Deignan Charles A. | CLSD | Employee Stock Option (right to buy) | D | 1,24 | 100 000 | 100 000 | |||||
| 2019-02-07 | 2019-02-05 | 4 | Raymond Brion S. | CLSD | Employee Stock Option (right to buy) | D | 1,24 | 100 000 | 100 000 | |||||
| 2018-12-06 | 2018-12-06 | 4 | Thorp Clay | CLSD | Common Stock | D | 1,3600 | 8 000 | 11 | 8 000 | ||||
| 2018-09-28 | 2018-09-26 | 4 | EDWARDS JEFFREY L | CLSD | Stock Option (right to buy) | D | 6,03 | 22 500 | 22 500 | |||||
| 2018-06-26 | 2018-06-25 | 4 | Cagle Gerald D. | CLSD | Stock Option (right to buy) | D | 9,11 | −2 632 | 0 | |||||
| 2018-06-26 | 2018-06-25 | 4 | Cagle Gerald D. | CLSD | Stock Option (right to buy) | D | 8,81 | −8 618 | 0 | |||||
| 2018-06-26 | 2018-06-25 | 4 | Cagle Gerald D. | CLSD | Common Stock | D | 9,1100 | 2 632 | 24 | 80 145 | ||||
| 2018-06-26 | 2018-06-25 | 4 | Cagle Gerald D. | CLSD | Common Stock | D | 8,8100 | 8 618 | 76 | 77 513 | ||||
| 2018-06-21 | 2018-06-20 | 4 | Croarkin Richard | CLSD | Stock Option (right to buy) | D | 10,74 | 11 250 | 11 250 | |||||
| 2018-06-21 | 2018-06-20 | 4 | Humphries William D. | CLSD | Stock Option (right to buy) | D | 10,74 | 11 250 | 11 250 | |||||
| 2018-06-21 | 2018-06-20 | 4 | LASEZKAY GEORGE M | CLSD | Stock Option (right to buy) | D | 10,74 | 11 250 | 11 250 | |||||
| 2018-06-21 | 2018-06-20 | 4 | SHAFFER CHRISTY L | CLSD | Stock Option (right to buy) | D | 10,74 | 11 250 | 11 250 | |||||
| 2018-06-21 | 2018-06-20 | 4 | Thorp Clay | CLSD | Stock Option (right to buy) | D | 10,74 | 11 250 | 11 250 | |||||
| 2018-06-21 | 2018-06-20 | 4 | Zaytsev Evgeny | CLSD | Stock Option (right to buy) | D | 10,74 | 11 250 | 11 250 | |||||
| 2018-06-21 | 2018-06-20 | 4 | Cagle Gerald D. | CLSD | Stock Option (right to buy) | D | 10,74 | 11 250 | 11 250 | |||||
| 2018-06-04 | 2018-06-04 | 4 | White Daniel H. | CLSD | Common Stock | D | 9,0700 | 11 000 | 100 | 483 335 | ||||
| 2018-06-04 | 2018-03-28 | 4 | White Daniel H. | CLSD | Common Stock | D | −2 000 | 472 335 | ||||||
| 2018-05-21 | 2018-05-18 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 13,1600 | −61 139 | −805 | 3 466 394 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 13,0300 | −100 000 | −1 303 | 3 527 533 | ||||
| 2018-05-15 | 2018-05-11 | 4 | Cagle Gerald D. | CLSD | Stock Option (right to buy) | D | 0,40 | −45 454 | 0 | |||||
| 2018-05-15 | 2018-05-11 | 4 | Cagle Gerald D. | CLSD | Common Stock | D | 0,4000 | 45 454 | 18 | 68 895 | ||||
| 2018-03-26 | 2018-03-23 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 11,7900 | 500 | 6 | 66 356 | ||||
| 2018-03-23 | 2018-03-23 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 12,0200 | −5 231 | −63 | 3 627 533 | ||||
| 2018-03-23 | 2018-03-22 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 12,0700 | −33 630 | −406 | 3 632 764 | ||||
| 2018-03-23 | 2018-03-21 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 12,2700 | −100 000 | −1 227 | 3 666 394 | ||||
| 2018-03-23 | 2018-03-22 | 4 | Cagle Gerald D. | CLSD | Common Stock | D | 11,8900 | 7 500 | 89 | 23 441 | ||||
| 2018-02-27 | 2018-02-26 | 4 | Raymond Brion S. | CLSD | Employee Stock Option (right to buy) | D | 6,23 | 80 000 | 80 000 | |||||
| 2017-12-12 | 2017-12-08 | 4 | Deignan Charles A. | CLSD | Employee Stock Option (right to buy) | D | 5,89 | 96 000 | 96 000 | |||||
| 2017-12-12 | 2017-12-08 | 4 | White Daniel H. | CLSD | Employee Stock Option (right to buy) | D | 5,89 | 221 500 | 221 500 | |||||
| 2017-12-12 | 2017-12-08 | 4 | Noronha Glenn | CLSD | Employee Stock Option (right to buy) | D | 5,89 | 96 000 | 96 000 | |||||
| 2017-12-07 | 2017-12-07 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 6,1300 | −5 000 | −31 | 3 766 394 | ||||
| 2017-12-07 | 2017-12-06 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 6,0900 | −15 000 | −91 | 3 771 394 | ||||
| 2017-12-07 | 2017-12-05 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 6,3700 | −15 000 | −96 | 3 786 394 | ||||
| 2017-11-16 | 2017-11-16 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 6,9900 | −5 000 | −35 | 3 801 394 | ||||
| 2017-11-16 | 2017-11-15 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 6,9900 | −15 000 | −105 | 3 806 394 | ||||
| 2017-11-16 | 2017-11-14 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,0200 | −15 000 | −105 | 3 821 394 | ||||
| 2017-10-23 | 2017-10-19 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 7,8100 | −400 | −3 | 35 309 | ||||
| 2017-10-23 | 2017-10-19 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,8100 | −3 600 | −28 | 474 335 | ||||
| 2017-10-23 | 2017-10-18 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 7,8200 | −400 | −3 | 35 709 | ||||
| 2017-10-23 | 2017-10-18 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,8200 | −3 600 | −28 | 477 935 | ||||
| 2017-10-05 | 2017-10-05 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,3400 | −6 000 | −50 | 3 836 394 | ||||
| 2017-10-05 | 2017-10-04 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,5900 | −14 000 | −120 | 3 842 394 | ||||
| 2017-10-05 | 2017-10-03 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,6400 | −15 000 | −130 | 3 856 394 | ||||
| 2017-09-15 | 2017-09-15 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,5400 | −10 000 | −75 | 3 871 394 | ||||
| 2017-09-15 | 2017-09-14 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,5200 | −6 000 | −45 | 3 881 394 | ||||
| 2017-09-15 | 2017-09-13 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,4900 | −8 500 | −64 | 3 887 394 | ||||
| 2017-09-11 | 2017-09-08 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 7,6300 | −600 | −5 | 36 109 | ||||
| 2017-09-11 | 2017-09-08 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,6300 | −5 400 | −41 | 481 535 | ||||
| 2017-09-11 | 2017-09-07 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 7,5300 | −1 000 | −8 | 36 709 | ||||
| 2017-09-11 | 2017-09-07 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,5300 | −9 000 | −68 | 486 935 | ||||
| 2017-08-16 | 2017-08-15 | 4 | SHAFFER CHRISTY L | CLSD | Common Stock | D | 7,0000 | 1 100 | 8 | 4 400 | ||||
| 2017-08-15 | 2017-08-11 | 4 | Cagle Gerald D. | CLSD | Common Stock | D | 7,0800 | 5 000 | 35 | 15 941 | ||||
| 2017-08-14 | 2017-08-14 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 7,0650 | 1 000 | 7 | 65 309 | ||||
| 2017-08-10 | 2017-08-08 | 4 | LASEZKAY GEORGE M | CLSD | Stock Option (right to buy) | D | 7,96 | 22 500 | 22 500 | |||||
| 2017-08-09 | 2017-08-09 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,3000 | −15 000 | −110 | 3 895 894 | ||||
| 2017-08-09 | 2017-08-08 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,9800 | −5 000 | −40 | 3 910 894 | ||||
| 2017-08-09 | 2017-08-07 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,0200 | −4 500 | −36 | 3 915 894 | ||||
| 2017-07-21 | 2017-07-20 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 9,7100 | −400 | −4 | 37 709 | ||||
| 2017-07-21 | 2017-07-20 | 4 | White Daniel H. | CLSD | Common Stock | D | 9,7100 | −3 600 | −35 | 496 367 | ||||
| 2017-07-21 | 2017-07-19 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 9,7900 | −400 | −4 | 38 109 | ||||
| 2017-07-21 | 2017-07-19 | 4 | White Daniel H. | CLSD | Common Stock | D | 9,7900 | −3 600 | −35 | 499 967 | ||||
| 2017-07-05 | 2017-06-30 | 4 | Thorp Clay | CLSD | Stock Option (right to buy) | D | 9,11 | 2 632 | 2 632 | |||||
| 2017-07-05 | 2017-06-30 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 7,7400 | 1 550 | 12 | 64 309 | ||||
| 2017-07-05 | 2017-06-30 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,7400 | 3 100 | 24 | 503 567 | ||||
| 2017-07-05 | 2017-06-30 | 4 | Yoon Derek | CLSD | Stock Option (right to buy) | D | 9,11 | 2 632 | 2 632 | |||||
| 2017-07-05 | 2017-06-30 | 4 | Zaytsev Evgeny | CLSD | Stock Option (right to buy) | D | 9,11 | 2 632 | 2 632 | |||||
| 2017-07-05 | 2017-06-30 | 4 | Cagle Gerald D. | CLSD | Stock Option (right to buy) | D | 9,11 | 2 632 | 2 632 | |||||
| 2017-07-05 | 2017-06-30 | 4 | Humphries William D. | CLSD | Stock Option (right to buy) | D | 9,11 | 2 632 | 2 632 | |||||
| 2017-07-05 | 2017-06-30 | 4 | Croarkin Richard | CLSD | Stock Option (right to buy) | D | 9,11 | 2 632 | 2 632 | |||||
| 2017-07-05 | 2017-06-30 | 4 | SHAFFER CHRISTY L | CLSD | Stock Option (right to buy) | D | 9,11 | 2 632 | 2 632 | |||||
| 2017-06-23 | 2017-06-22 | 4 | SHAFFER CHRISTY L | CLSD | Stock Option (right to buy) | D | 8,81 | 8 618 | 8 618 | |||||
| 2017-06-23 | 2017-06-22 | 4 | Cagle Gerald D. | CLSD | Stock Option (right to buy) | D | 8,81 | 8 618 | 8 618 | |||||
| 2017-06-23 | 2017-06-22 | 4 | Croarkin Richard | CLSD | Stock Option (right to buy) | D | 8,81 | 8 618 | 8 618 | |||||
| 2017-06-23 | 2017-06-22 | 4 | Humphries William D. | CLSD | Stock Option (right to buy) | D | 8,81 | 8 618 | 8 618 | |||||
| 2017-06-23 | 2017-06-22 | 4 | Thorp Clay | CLSD | Stock Option (right to buy) | D | 8,81 | 8 618 | 8 618 | |||||
| 2017-06-23 | 2017-06-22 | 4 | Yoon Derek | CLSD | Stock Option (right to buy) | D | 8,81 | 8 618 | 8 618 | |||||
| 2017-06-23 | 2017-06-22 | 4 | Zaytsev Evgeny | CLSD | Stock Option (right to buy) | D | 8,81 | 8 618 | 8 618 | |||||
| 2017-06-14 | 2017-06-14 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 7,9900 | −400 | −3 | 38 509 | ||||
| 2017-06-14 | 2017-06-14 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,9900 | −3 600 | −29 | 500 467 | ||||
| 2017-06-14 | 2017-06-13 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 7,7800 | −400 | −3 | 38 909 | ||||
| 2017-06-14 | 2017-06-13 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,7800 | −3 600 | −28 | 504 067 | ||||
| 2017-05-23 | 2017-05-22 | 4 | SHAFFER CHRISTY L | CLSD | Common Stock | D | 8,0000 | 1 100 | 9 | 3 300 | ||||
| 2017-05-19 | 2017-05-19 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,3100 | −15 000 | −125 | 3 920 394 | ||||
| 2017-05-19 | 2017-05-18 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,4400 | −9 000 | −76 | 3 935 394 | ||||
| 2017-05-19 | 2017-05-18 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 8,4400 | −400 | −3 | 39 309 | ||||
| 2017-05-19 | 2017-05-18 | 4 | White Daniel H. | CLSD | Common Stock | D | 8,4400 | −3 600 | −30 | 507 667 | ||||
| 2017-05-19 | 2017-05-17 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 8,3800 | −400 | −3 | 39 709 | ||||
| 2017-05-19 | 2017-05-17 | 4 | White Daniel H. | CLSD | Common Stock | D | 8,3800 | −3 600 | −30 | 511 267 | ||||
| 2017-05-17 | 2017-05-17 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,3900 | −19 000 | −159 | 3 944 394 | ||||
| 2017-05-17 | 2017-05-16 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,6100 | −9 544 | −82 | 3 963 394 | ||||
| 2017-05-17 | 2017-05-15 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,9400 | −15 941 | −143 | 3 972 938 | ||||
| 2017-05-01 | 2017-03-27 | 4 | Cagle Gerald D. | CLSD | Common Stock | I | 7,1000 | 14 064 | 100 | 14 064 | ||||
| 2017-04-19 | 2017-04-19 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,3700 | −2 030 | −15 | 3 988 879 | ||||
| 2017-04-19 | 2017-04-18 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,4800 | −44 455 | −333 | 3 990 909 | ||||
| 2017-04-19 | 2017-04-17 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,4300 | −22 000 | −163 | 4 035 364 | ||||
| 2017-04-05 | 2017-04-04 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 7,5400 | −400 | −3 | 40 109 | ||||
| 2017-04-05 | 2017-04-04 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,5400 | −3 600 | −27 | 523 617 | ||||
| 2017-04-05 | 2017-04-03 | 4 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 7,5600 | −400 | −3 | 40 509 | ||||
| 2017-04-05 | 2017-04-03 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,5600 | −3 600 | −27 | 527 217 | ||||
| 2017-03-22 | 2017-03-20 | 4 | SHAFFER CHRISTY L | CLSD | Common Stock | D | 6,9000 | 2 200 | 15 | 2 200 | ||||
| 2017-03-20 | 2017-03-16 | 4 | Cagle Gerald D. | CLSD | Common Stock | D | 6,8400 | 5 000 | 34 | 10 941 | ||||
| 2017-03-17 | 2017-03-16 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 6,7700 | −21 485 | −145 | 4 057 364 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 6,4700 | −47 000 | −304 | 4 078 849 | ||||
| 2017-02-22 | 2017-02-22 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,4900 | −2 000 | −15 | 4 125 849 | ||||
| 2017-02-22 | 2017-02-21 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,5500 | −25 000 | −189 | 4 127 849 | ||||
| 2017-02-17 | 2017-02-17 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,5400 | −10 000 | −75 | 4 152 849 | ||||
| 2017-02-17 | 2017-02-16 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,5800 | −14 000 | −106 | 4 162 849 | ||||
| 2017-02-17 | 2017-02-15 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,6400 | −17 485 | −134 | 4 176 849 | ||||
| 2017-01-20 | 2017-01-20 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,7700 | −8 000 | −62 | 4 194 334 | ||||
| 2017-01-20 | 2017-01-19 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,2300 | −15 485 | −127 | 4 202 334 | ||||
| 2017-01-20 | 2017-01-18 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,6400 | −25 000 | −216 | 4 217 819 | ||||
| 2017-01-20 | 2017-01-17 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 8,9200 | −20 000 | −178 | 4 242 819 | ||||
| 2017-01-19 | 2017-01-19 | 4 | Hatteras Venture Advisors III, LLC | CLSD | Common Stock | I | 8,2200 | −6 478 | −53 | 1 757 719 | ||||
| 2017-01-19 | 2017-01-18 | 4 | Hatteras Venture Advisors III, LLC | CLSD | Common Stock | I | 8,6400 | −10 457 | −90 | 1 764 197 | ||||
| 2017-01-19 | 2017-01-17 | 4 | Hatteras Venture Advisors III, LLC | CLSD | Common Stock | I | 8,9200 | −8 366 | −75 | 1 774 654 | ||||
| 2017-01-19 | 2017-01-19 | 4 | Hatteras Venture Advisors IV SBIC, LLC | CLSD | Common Stock | I | 8,2200 | −7 592 | −62 | 2 060 514 | ||||
| 2017-01-19 | 2017-01-18 | 4 | Hatteras Venture Advisors IV SBIC, LLC | CLSD | Common Stock | I | 8,6400 | −12 258 | −106 | 2 068 106 | ||||
| 2017-01-19 | 2017-01-17 | 4 | Hatteras Venture Advisors IV SBIC, LLC | CLSD | Common Stock | I | 8,9200 | −9 806 | −87 | 2 080 364 | ||||
| 2016-12-19 | 2016-12-15 | 4 | Noronha Glenn | CLSD | Employee Stock Option (right to buy) | D | 8,90 | 73 000 | 73 000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | Deignan Charles A. | CLSD | Employee Stock Option (right to buy) | D | 8,90 | 96 000 | 96 000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | White Daniel H. | CLSD | Employee Stock Option (right to buy) | D | 8,90 | 238 000 | 238 000 | |||||
| 2016-07-25 | 2016-07-21 | 4 | Noronha Glenn | CLSD | Employee Stock Option (right to buy) | D | 6,49 | 30 000 | 30 000 | |||||
| 2016-07-25 | 2016-07-21 | 4 | Deignan Charles A. | CLSD | Employee Stock Option (right to buy) | D | 6,49 | 30 000 | 30 000 | |||||
| 2016-07-25 | 2016-07-21 | 4 | White Daniel H. | CLSD | Employee Stock Option (right to buy) | D | 6,49 | 60 000 | 60 000 | |||||
| 2016-06-13 | 3 | Chen Bihua | CLSD | Common Stock | I | 3 976 416 | ||||||||
| 2016-06-13 | 3 | Chen Bihua | CLSD | Common Stock | I | 3 976 416 | ||||||||
| 2016-06-13 | 3 | Chen Bihua | CLSD | Common Stock | I | 3 976 416 | ||||||||
| 2016-06-13 | 3 | Chen Bihua | CLSD | Common Stock | I | 3 976 416 | ||||||||
| 2016-06-13 | 3 | Chen Bihua | CLSD | Common Stock | I | 3 976 416 | ||||||||
| 2016-06-07 | 2016-06-07 | 4 | RMI Investments S.a.r.l. | CLSD | Series B Preferred Stock | D | −2 594 677 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | RMI Investments S.a.r.l. | CLSD | Common Stock | D | 7,0000 | 42 857 | 300 | 1 558 024 | ||||
| 2016-06-07 | 2016-06-07 | 4 | RMI Investments S.a.r.l. | CLSD | Common Stock | D | 1 179 398 | 1 515 167 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Cagle Gerald D. | CLSD | Warrant to Purchase Common Stock (right to buy) | D | 0,02 | −470 | 0 | |||||
| 2016-06-07 | 2016-06-07 | 4 | Cagle Gerald D. | CLSD | Series B Preferred Stock | D | −9 375 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Cagle Gerald D. | CLSD | Common Stock | D | 7,0000 | −2 | −0 | 5 941 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Cagle Gerald D. | CLSD | Common Stock | D | 0,0220 | 470 | 0 | 5 943 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Cagle Gerald D. | CLSD | Common Stock | D | 4 261 | 5 473 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay By Hatteras Venture Partners IV SBIC, LP | CLSD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | −21 705 | 0 | |||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay By Hatteras Venture Affiliates III, LP | CLSD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | −1 805 | 0 | |||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay By Hatteras Venture Partners III, LP | CLSD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | −19 900 | 0 | |||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay See Footnotes | CLSD | Series C Preferred Stock | I | −675 795 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay See Footnotes | CLSD | Series B Preferred Stock | I | −865 881 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay See Footnotes | CLSD | Series A-1 Preferred Stock | I | −1 654 531 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay See Footnotes | CLSD | Series A Preferred Stock | I | −4 071 815 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,0000 | 785 714 | 5 500 | 4 262 819 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 7,0000 | −138 | −1 | 3 477 105 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 0,0220 | 43 410 | 1 | 3 477 243 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 3 321 785 | 3 433 833 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Deignan Charles A. | CLSD | Warrant to Purchase Common Stock (right to buy) | D | 0,02 | −470 | 0 | |||||
| 2016-06-07 | 2016-06-07 | 4 | Deignan Charles A. | CLSD | Series B Preferred Stock | D | −9 375 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 7,0000 | −2 | −0 | 62 759 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 0,0220 | 470 | 0 | 62 761 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Deignan Charles A. | CLSD | Common Stock | D | 4 261 | 62 291 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | White Daniel H. | CLSD | Warrant to Purchase Common Stock (right to buy) | D | 0,02 | −657 | 0 | |||||
| 2016-06-07 | 2016-06-07 | 4 | White Daniel H. | CLSD | Series B Preferred Stock | D | −13 110 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | White Daniel H. | CLSD | Series A Preferred Stock | D | −133 234 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | White Daniel H. | CLSD | Common Stock | D | 7,0000 | −3 | −0 | 530 817 | ||||
| 2016-06-07 | 2016-06-07 | 4 | White Daniel H. | CLSD | Common Stock | D | 0,0220 | 657 | 0 | 530 820 | ||||
| 2016-06-07 | 2016-06-07 | 4 | White Daniel H. | CLSD | Common Stock | D | 66 518 | 530 163 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP | CLSD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | −1 805 | 0 | |||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP | CLSD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | −19 900 | 0 | |||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC See Footnotes | CLSD | Series C Preferred Stock | I | −337 898 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC See Footnotes | CLSD | Series B Preferred Stock | I | −432 940 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC See Footnotes | CLSD | Series A-1 Preferred Stock | I | −689 388 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC See Footnotes | CLSD | Series A Preferred Stock | I | −2 035 907 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC See Footnotes | CLSD | Common Stock | I | 7,0000 | 107 142 | 750 | 1 783 020 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC See Footnotes | CLSD | Common Stock | I | 7,0000 | −69 | −0 | 1 675 878 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC See Footnotes | CLSD | Common Stock | I | 0,0220 | 21 705 | 0 | 1 675 947 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors III, LLC See Footnotes | CLSD | Common Stock | I | 1 598 219 | 1 654 242 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors IV SBIC, LLC By Hatteras Venture Partners IV SBIC, LP | CLSD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | −21 705 | 0 | |||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors IV SBIC, LLC By Hatteras Venture Partners IV SBIC, LP | CLSD | Series C Preferred Stock | I | −337 897 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors IV SBIC, LLC By Hatteras Venture Partners IV SBIC, LP | CLSD | Series B Preferred Stock | I | −432 941 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors IV SBIC, LLC By Hatteras Venture Partners IV SBIC, LP | CLSD | Series A-1 Preferred Stock | I | −689 388 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors IV SBIC, LLC By Hatteras Venture Partners IV SBIC, LP | CLSD | Series A Preferred Stock | I | −2 035 908 | 0 | ||||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors IV SBIC, LLC By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 7,0000 | 414 286 | 2 900 | 2 090 170 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors IV SBIC, LLC By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 7,0000 | −69 | −0 | 1 675 884 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors IV SBIC, LLC By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 0,0220 | 21 705 | 0 | 1 675 953 | ||||
| 2016-06-07 | 2016-06-07 | 4 | Hatteras Venture Advisors IV SBIC, LLC By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 1 598 223 | 1 654 248 | ||||||
| 2016-06-01 | 3 | Cagle Gerald D. | CLSD | Common Stock | D | 2 424 | ||||||||
| 2016-06-01 | 3 | Cagle Gerald D. | CLSD | Common Stock | D | 2 424 | ||||||||
| 2016-06-01 | 3 | Deignan Charles A. | CLSD | Common Stock | D | 116 060 | ||||||||
| 2016-06-01 | 3 | Deignan Charles A. | CLSD | Common Stock | D | 116 060 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 112 046 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 112 046 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 112 046 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 112 046 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 112 046 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 112 046 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 112 046 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 112 046 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 112 046 | ||||||||
| 2016-06-01 | 3 | Thorp Clay By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 112 050 | ||||||||
| 2016-06-01 | 3 | Thorp Clay By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 112 050 | ||||||||
| 2016-06-01 | 3 | Thorp Clay By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 112 050 | ||||||||
| 2016-06-01 | 3 | Thorp Clay By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 112 050 | ||||||||
| 2016-06-01 | 3 | Thorp Clay By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 112 050 | ||||||||
| 2016-06-01 | 3 | Thorp Clay By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 112 050 | ||||||||
| 2016-06-01 | 3 | Thorp Clay By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 112 050 | ||||||||
| 2016-06-01 | 3 | Thorp Clay By Hatteras Venture Partners IV SBIC, LP | CLSD | Common Stock | I | 112 050 | ||||||||
| 2016-06-01 | 3 | RusnanoMedInvest LLC | CLSD | Common Stock | D | 671 538 | ||||||||
| 2016-06-01 | 3 | RusnanoMedInvest LLC | CLSD | Common Stock | D | 671 538 | ||||||||
| 2016-06-01 | 3 | RusnanoMedInvest LLC | CLSD | Common Stock | D | 671 538 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 224 096 | ||||||||
| 2016-06-01 | 3 | Thorp Clay See Footnotes | CLSD | Common Stock | I | 224 096 | ||||||||
| 2016-06-01 | 3 | White Daniel H. As UTMA custodian for son | CLSD | Common Stock | I | 507 188 | ||||||||
| 2016-06-01 | 3 | White Daniel H. As UTMA custodian for son | CLSD | Common Stock | I | 507 731 | ||||||||
| 2016-06-01 | 3 | White Daniel H. | CLSD | Common Stock | D | 970 532 | ||||||||
| 2016-06-01 | 3 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 547 796 | ||||||||
| 2016-06-01 | 3 | White Daniel H. As UTMA custodian for son | CLSD | Common Stock | I | 507 188 | ||||||||
| 2016-06-01 | 3 | White Daniel H. As UTMA custodian for son | CLSD | Common Stock | I | 507 731 | ||||||||
| 2016-06-01 | 3 | White Daniel H. As UTMA custodian for son | CLSD | Common Stock | I | 508 075 | ||||||||
| 2016-06-01 | 3 | White Daniel H. As UTMA custodian for son | CLSD | Common Stock | I | 508 075 | ||||||||
| 2016-06-01 | 3 | White Daniel H. | CLSD | Common Stock | D | 970 532 | ||||||||
| 2016-06-01 | 3 | White Daniel H. By White Family Trust | CLSD | Common Stock | I | 547 796 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
